Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Engcan77on Sep 15, 2022 3:53pm
109 Views
Post# 34965303

RE:RE:RE:RE:LOOKING PRETTY SICK, HOWHEE!

RE:RE:RE:RE:LOOKING PRETTY SICK, HOWHEE!Well, we've been waiting appox 3 months since the announcement that Dr Bieber was looking to help with a structure change within Sirona. Not sure if it should take 3 months to achieve this goal, seeing the size of the company.  So either they all took the Summer off, are looking for a new CEO or Howard has nixed the idea...not liking what he put forward.
I presume Dr Bieber needed time to asses everything, however how many more months will Howard be able to draw a nice income from Sirona. It is overdue he was replaced.
The amount of the upfront payment and ongoing payments from Abbvie is important. The question is...who can they afford. Maybe they will have to wait for another deal to come to fruition to afford someone decent. That's if the Abbvie deal doesn't cut it, for the short term change.
<< Previous
Bullboard Posts
Next >>